Multiple Sclerosis In The Crossfire 2008: New Therapies for MS

CME Information

Earn Hours of AMA PRA Category 1 Credit™

In the Crossfire 2008: The Emerging Face of MS: Part 1

Time to Complete Activity: 1 hour 17 minutes

Designation Statement

Ciné-Med, Inc. designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience

This activity is intended for neurologists and other medical professionals with a specific interest in the management of Multiple Sclerosis.

Recorded: Oct. 28, 2008
Release Date: Jan. 15, 2009
Expiration Date: Jan. 15, 2011

Learning Objectives:

At the conclusion of this continuing medical education activity, participants should be able to:

Discuss the relationship of infections to MS
Describe Immunomodulatory effects of Vitamin D
Explain the role of B-cells in MS
Describe the long-term effect of disease-modifying therapy in MS
Discuss the relationship of early therapy of CIS with long-term disability
Discuss results of the REGARD and BEYOND trials in RRMS

How to get CME credit

To receive credit, participants must view the webcast or DVD, register on this site, and successfully complete the post-test and evaluation (successful passing grade ≥70%). Certificates can be printed on line.

Accreditation

These educational activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Ciné-Med, Inc. and Astute Technology. Ciné-Med, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure statement

Ciné-Med, Inc., in accordance with the ACCME’s Standards for Commercial Support, requires individuals with control over content to disclose to learners any relevant financial relationships(s). Faculty disclosures can be found on the Faculty page.